Celgene (CELG), Biotech Peers Pressured on Market Open
Tweet
Share
E-mail
Get Alerts CELG Hot Sheet
Join SI Premium – FREE
Celgene (NASDAQ: CELG), Biotech Peers Pressured on Market Open
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
- KKR offered to buy UGI for $42.50 a share - WSJ
- UGI Corp. (UGI) halted on volatility, up 6%
Create E-mail Alert Related Categories
ETFs, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
